CETI - Centro de Estudos em Terapias Inovadoras

Curitiba, Paraná 80030-110

0 studies enrolling now · 2 studies all time

What they study most

Covid19, Post-acute COVID-19 Respiratory Disease, Rheumatoid Arthritis

Studies at this site

• LYT-100 in Post-acute COVID-19 Respiratory Disease — Stopped early
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed